Karen H Costenbader

Featured in: Favicon

nih.gov

nature.com Favicon

wiley.com

bmj.com (+1) Favicon

jamanetwork.com Favicon

medpagetoday.com Favicon

healio.com Favicon

jacionline.org Favicon

ehp.niehs.nih.gov Favicon

onlinelibrary.wiley.com

Articles

Models to predict lupus based on genetics, lifestyle perform ‘very well in all situations’

Nov 17, 2024 | healio.com | Justin Cooper |Shenaz Bagha |Karen H Costenbader

Read more You've successfully added Lupus to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
Women with high ultraprocessed food intake have 56% greater lupus risk

Aug 28, 2024 | healio.com | Justin Cooper |Shenaz Bagha |Karen H Costenbader

You've successfully added Lupus to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways:Women in the highest tertile of ultraprocessed food consumption had a 56% greater chance of SLE vs. the lowest. Sugar- or artificially sweetened beverages were most strongly associated with SLE.
‘Earlier use of biologics’ like belimumab may improve long-term lupus outcomes

Jun 20, 2024 | healio.com | Rob Volansky |Shenaz Bagha |Karen H Costenbader

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Early use of biologics like belimumab may limit complications associated with steroid use and improve long-term outcomes in systemic lupus erythematosus, according to data presented at the EULAR 2024 Congress.
‘Very important’: Belimumab decreases lupus flare vs placebo in early, established disease

Jun 12, 2024 | healio.com | Justin Cooper |Shenaz Bagha |Karen H Costenbader

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
Vitamin D and Marine n‐3 Fatty Acids for Autoimmune Disease Prevention: Outcomes at Two Years after VITAL Trial Completion

Jan 26, 2024 | acrjournals.onlinelibrary.wiley.com | Karen H Costenbader |Nancy Cook |I-Min Lee |Jill Hahn

Supporting Information Filename Description art42811-sup-0001-Disclosureform.pdfPDF document, 381.6 KB Disclosure Form
Shifting the SLE management paradigm: challenges and implications - Nature Reviews Rheumatology

Dec 4, 2023 | nature.com | Karen H Costenbader

Newly published European guidelines for the management of systemic lupus erythematosus (SLE) and lupus nephritis, specifically recommending early and aggressive use of new medications, signal that the old paradigm of SLE management is shifting. Although it presents challenges, this shift is welcome — and is likely to have far-reaching implications. Refers to Fanouriakis, A. et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann. Rheum. Dis.
‘Tricky public health message’: Smoking, junk food boost lupus risk, alcohol reduces risk

Sep 7, 2023 | healio.com | Erich Martin |Shenaz Bagha |Karen H Costenbader

Source/Disclosures Source: Costenbader K. Pre-clinical autoimmunity: Identifying risk factors and developing strategies against disease development in SLE. Presented at The Congress of Clinical Rheumatology West; Sept. 7-10, 2023. (hybrid meeting). Disclosures: Costenbader reports financial disclosures with Amgen, Astra Zeneca, Bristol Myers Squibb, Cabaletta, Gilead, GlaxoSmithKline, Exagen, Janssen, Lilly and Merck. You've successfully added Rheumatology: Lupus to your alerts.
Response to: Correspondence on “European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance” by Bossuyt et al | Annals of the Rheumatic Diseases

Jul 13, 2023 | ard.bmj.com | Martin Aringer |Karen H Costenbader |Nicolai Leuchten |Thomas Ernst Dorner

http://orcid.org/0000-0003-4471-8375Martin Aringer1, Karen Costenbader2, Nicolai Leuchten1, http://orcid.org/0000-0002-6478-7725Thomas Dörner3, http://orcid.org/0000-0003-0591-2976Sindhu R Johnson4 1 Division of Rheumatology, Department of Medicine III, University Medical Center and Faculty of Medicine Carl Gustav Carus at the TU Dresden, Dresden, Germany 2 Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston,...

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Karen H Costenbader

Articles

Models to predict lupus based on genetics, lifestyle perform ‘very well in all situations’

Women with high ultraprocessed food intake have 56% greater lupus risk

‘Earlier use of biologics’ like belimumab may improve long-term lupus outcomes

‘Very important’: Belimumab decreases lupus flare vs placebo in early, established disease

Vitamin D and Marine n‐3 Fatty Acids for Autoimmune Disease Prevention: Outcomes at Two Years after VITAL Trial Completion

Shifting the SLE management paradigm: challenges and implications - Nature Reviews Rheumatology

‘Tricky public health message’: Smoking, junk food boost lupus risk, alcohol reduces risk

Response to: Correspondence on “European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance” by Bossuyt et al | Annals of the Rheumatic Diseases

Contact details

Emails

Socials & Sites